Key Details
Price
$23.55Annual Revenue
$0.00Annual ROE
-14.17%Beta
1.03Events Calendar
Next earnings date:
Mar 7, 2025Recent quarterly earnings:
Nov 13, 2024Recent annual earnings:
Mar 8, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Feb 28, 25 William Blair
OutperformFeb 28, 25 Citizens Capital Markets
Market OutperformJan 8, 25 Stifel
BuyDec 20, 24 HC Wainwright & Co.
BuyDec 19, 24 HC Wainwright & Co.
BuyDec 18, 24 JMP Securities
Market OutperformDec 4, 24 HC Wainwright & Co.
BuySep 23, 24 Morgan Stanley
OverweightSep 23, 24 Cantor Fitzgerald
OverweightSep 16, 24 Cantor Fitzgerald
OverweightMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Structure Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Structure Therapeutics?
- Does Structure Therapeutics pay dividends?
- What sector is Structure Therapeutics in?
- What industry is Structure Therapeutics in?
- What country is Structure Therapeutics based in?
- When did Structure Therapeutics go public?
- Is Structure Therapeutics in the S&P 500?
- Is Structure Therapeutics in the NASDAQ 100?
- Is Structure Therapeutics in the Dow Jones?
- When was Structure Therapeutics's last earnings report?
- When does Structure Therapeutics report earnings?
- Should I buy Structure Therapeutics stock now?
What is the ticker symbol for Structure Therapeutics?
The ticker symbol for Structure Therapeutics is NASDAQ:GPCR
Does Structure Therapeutics pay dividends?
No, Structure Therapeutics does not pay dividends
What sector is Structure Therapeutics in?
Structure Therapeutics is in the Healthcare sector
What industry is Structure Therapeutics in?
Structure Therapeutics is in the Biotechnology industry
What country is Structure Therapeutics based in?
Structure Therapeutics is headquartered in United States
When did Structure Therapeutics go public?
Structure Therapeutics's initial public offering (IPO) was on February 3, 2023
Is Structure Therapeutics in the S&P 500?
No, Structure Therapeutics is not included in the S&P 500 index
Is Structure Therapeutics in the NASDAQ 100?
No, Structure Therapeutics is not included in the NASDAQ 100 index
Is Structure Therapeutics in the Dow Jones?
No, Structure Therapeutics is not included in the Dow Jones index
When was Structure Therapeutics's last earnings report?
Structure Therapeutics's most recent earnings report was on Nov 13, 2024
When does Structure Therapeutics report earnings?
The next expected earnings date for Structure Therapeutics is Mar 7, 2025
Should I buy Structure Therapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions